4//SEC Filing
Gordon David N. 4
Accession 0001209191-21-017555
CIK 0001557746other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:42 PM ET
Size
19.4 KB
Accession
0001209191-21-017555
Insider Transaction Report
Form 4
Gordon David N.
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-03-01+20,600→ 108,135 total - Tax Payment
Common Stock
2021-03-01$24.06/sh−5,660$136,180→ 102,475 total - Exercise/Conversion
Common Stock
2021-03-02+8,297→ 110,772 total - Tax Payment
Common Stock
2021-03-02$23.25/sh−2,280$53,010→ 108,492 total - Award
Employee Stock Option (Right to Buy)
2021-03-01+99,500→ 99,500 totalExercise: $24.06Exp: 2031-02-28→ Common Stock (99,500 underlying) - Award
Restricted stock units
2021-03-01+28,400→ 28,400 total→ Common Stock (28,400 underlying) - Exercise/Conversion
Restricted stock units
2021-03-01−20,600→ 41,200 total→ Common Stock (20,600 underlying) - Exercise/Conversion
Restricted stock units
2021-03-02−8,297→ 24,892 total→ Common Stock (8,297 underlying)
Footnotes (6)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.
- [F3]Exercisable with respect to 25% of the shares subject to the option vesting on each of the first, second, third and fourth anniversaries of the grant date, subject to Reporting Person's continuous service through each such date.
- [F4]The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.
- [F5]The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.
- [F6]The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001751167
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:42 PM ET
- Size
- 19.4 KB